Sponsor Pipeline

Chongqing Peg-Bio Biopharm Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
6
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06512584 Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral… Short Bowel Syndrome Recruiting
Phase 2
NCT07704047 A Clinical Study of FT1 in Patients With Short Bowel Syndrome Short Bowel Syndrome Recruiting
Phase 1/2
NCT07446491 A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia… Thrombocytopenia Associated With Chronic Liver Disease Recruiting
Phase 1
NCT06880081 Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP) Primary Immune Thrombocytopenia (ITP) Recruiting
NCT07672756 A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With… Phenylketonuria (PKU) Recruiting
NCT07702162 A Clinical Study of PA5 in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
Get alerts when Chongqing Peg-Bio Biopharm Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free